Drugs / TMZ
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01670890 Comparator | Aug 2012 → Aug 2014 | malignant glioma | Peking Union Medical College Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TMZ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01670890 ↗ |
| Route | Oral | “TMZ was administered orally 50mg/m2/day,day 1 to 28,for 6 cycles” NCT01670890 ↗ |